A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancerHe Li, Renjun Peng, Yuqiu Tian et al.|Frontiers in Immunology|2022Cited by 6